Urinary nitrate is known to be a measure of environmental exposure. Only recently an endogenous metabolic pathway resulting in nitrate synthesis was described. We have determined the concentration of nitrate expressed äs nitrate/creatinine ratio in the urine of patients in whom a significant environmental nitrate load was presumed to be absent. A significant elevation of nitrates in patients with inflammatory bowel disease compared with patients with non-inflamrnatory disorders was observed (0.173 ± 0.155 vs. 0.037 ± 0.016 mol/mol creatinine, P < 0.01). Increased nitrate excretion in the urine of patients with inflammatory bowel disease may reflect the endogenous nitrate synthesis induced by the immune activation.
Introduction
Urinary nitrate is often determined to assess environmental nitrate exposure (1) . Only in the past few years, an endogenous metabolic pathway of nitrate production has been described (2) . Nitrate represents a metabolite of nitric oxide, a molecule with diverse biologic activity, including an important role in immunologic defences (2) . Recently, an increase in urinary nitrate excretion was reported iri experimentally induced inflammation (3) . Similar observations have been made in infectious diseases and ulcerative colitis (4, 5) , but such studies are still rare due to the obvious difficulty in excluding interference by exogenous nitrate ingestion and further nitrate degradatioü by bacteria infecting the lower urinary tract.
Materials and Methods
We measured urine nitrate in 24 patients, 18 males and 6 females, mean age 37 ± 17 years (ränge 16-68), in whom the exogenous nitrate load was minimized for various reasons (total parenteral nutrition, fasting in preparation for diagnostic tests, refusai to receive food, or low-nitrate diet, i. e. diet without high nitrate content foods such äs vegetables and ciired meat, for at least 48 hours before the sample collection, when the influence of the previous nitrate 'exposure is known to abate (1)). No patients with urinary tract infection or on indwelling urinary catheter were included, because urinary nitrate was often undetectable in these subjects due to further nitrate metabolism by infecting bacteria. Most of the disorders were represented only by one patient with the notable exception of inflammatory bowel disease. Seven patients with inflammatory bowel disease (6 with Crohn's disease and one with ulcerative colitis) were evaluated, äs total parenteral nutrition is frequently administered prior to Operation in this disorder. Activity of the disease was estirnated by assessment of clinical Symptoms and certain laboratory quantities in a rating system applicable for both Crohn's disease and ulcerative colitis (6) . Ten patients had a diagnosis not associated with inflammation (2 had obesity, 2 nonulcer dyspepsia and one each had Gilbert's syndrome, colon adenoma, irritable bowel syndrome, chronic fatigue syndrome, abdominal crisis in hypertriglyceridaemia and malnutrition resulting from refusai to receive foods). In patients with inflammatory bowel disease, äs well äs in the remaining 7 patients with gastric cancer, unclassified connective tissue disease, pneumatosis cystoides intestinalis, acute gastroenteritis, rheumatoid arthritis, vasculitis and sarcoidosis, some degree of inflammatory response is presumed to occur äs a result of the disease. A sample of the first morning urine was collected and stored at -20 °C until analysis.
Nitrate was determined by flow injection analysis using the Griess reaction with N-naphthylethylenediamine after reduction to nitrite by a cadmium column (7) . Urine specimens diluted l : 20 (35 ) were injected into the flow injection analyzer (FIA-20, JZD Plotiste, Hradec Kralove, Czech Republic). Ammonium chloride/sodium teträborate buffer was used äs eluent. The absorbance was read at 545 nm wavelength and recorded. The nitrate concentration was determined frorn a calibration curve which was linear in the interval from 0.01 to 0.33 mmol/l. Creatinine was measured by the Jaffe reaction with picric acid in alkaline solution on an automated analyzer (Hitachi 704) after dilution of the sample with distilled water l : 50. The results were expressed äs nitrate/creatinine ratio (mol/mol). 
Results and Discussion
The mean nitrate concentration in the whole group was 0.109 ± 0.124 mol/mol creatinine (ränge 0.017-0.400 mol/mol creatinine). The nitrate values in patients with inflammatory bowel disease were significantly higher than in subjects with disorders not associated with inflammatory response (0.173 ±0.155, ränge 0.026-0.400 mol/mol creatinine, vs 0.037 ± 0.016, ränge 0.017-0.077 mol/mol creatinine, P < 0.01). The ur> nary nitrate excretion and some of clinical data of the patients with inflammatory bowel disease are shown in tab. 1. Elevated urinary nitrate in inflammatory bowel disease is of interest in the light of previous studies in patients with ulcerative colitis (4, 8) and may reflect increased production of nitric oxide by activated macrophages in the course of the disorder.
Among the subjects with other disorder associated with inflammatory response, individual patients with unclassified connective tissue disease, pneurnatqsis cystpides intestinalis and acüte gastroenteritis also had urinary nitrate excretion outside the ränge observed in the group with non-inflammatory disorders (0.201, 0.294 and 0.373 mol/mol creatinine, respectively), while in others the urinary nitrate excretions were not conspicuous.
The data from the present preliminary study indicate that examining the first morning urine specimen niäy be a feasible alternative to a 24-hour urine collection in studying urinary nitrate excretion. Endogenous nitrate excretion appears to reach detectable values in inflammatory bowel disease, possibly reflecting the immunedependent nitric oxide production.
